Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Berna

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 14, 2021
Recommendations of the schizophrenia expert center network for the screening prevention and treatment of sleep disorders based on the results from the real-world schizophrenia FACE-SZ national cohortP L Sunhary de Verville, D Etchecopar-Etchart, R Richieri, et al.
Psychopharmacology|December 4, 2015
Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ datasetG Fond, L Boyer, M Favez, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 12, 2017
Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohortG Fond, N Resseguier, F Schürhoff, et al.
European Archives of Psychiatry and Clinical Neuroscience|May 30, 2018
Chronic low-grade peripheral inflammation is associated with ultra resistant schizophrenia. Results from the FACE-SZ cohortG Fond, O Godin, L Boyer, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 1, 2017
Cigarette smoking and schizophrenia: a specific clinical and therapeutic profile? Results from the FACE-Schizophrenia cohortJ Mallet, Y Le Strat, F Schürhoff, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 19, 2022
The impact of parent history of severe mental illness on schizophrenia outcomes: results from the real-world FACE-SZ cohortA Garosi, P L Sunhary de Verville, D Etchecopar-Etchart, et al.
Journal of Affective Disorders|July 16, 2020
Major depression, sleep, hostility and body mass index are associated with impaired quality of life in schizophrenia. Results from the FACE-SZ cohortG Fond, T Korchia, P L Sunhary de Verville, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 29, 2017
Benzodiazepine long-term administration is associated with impaired attention/working memory in schizophrenia: results from the national multicentre FACE-SZ data setGuillaume Fond, F Berna, L Boyer, et al.
Schizophrenia Research|September 11, 2017
Risk factors for increased duration of untreated psychosis. Results from the FACE-SZ datasetG Fond, L Boyer, M Andrianarisoa, et al.
Journal of Affective Disorders|December 18, 2015
Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data setG Fond, O Godin, L Brunel, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Progress in Neuro-Psychopharmacology & Biological Psychiatry|February 14, 2021
Recommendations of the schizophrenia expert center network for the screening prevention and treatment of sleep disorders based on the results from the real-world schizophrenia FACE-SZ national cohortP L Sunhary de Verville, D Etchecopar-Etchart, R Richieri, et al.
Psychopharmacology|December 4, 2015
Medication and aggressiveness in real-world schizophrenia. Results from the FACE-SZ datasetG Fond, L Boyer, M Favez, et al.
European Archives of Psychiatry and Clinical Neuroscience|November 12, 2017
Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohortG Fond, N Resseguier, F Schürhoff, et al.
European Archives of Psychiatry and Clinical Neuroscience|May 30, 2018
Chronic low-grade peripheral inflammation is associated with ultra resistant schizophrenia. Results from the FACE-SZ cohortG Fond, O Godin, L Boyer, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|July 1, 2017
Cigarette smoking and schizophrenia: a specific clinical and therapeutic profile? Results from the FACE-Schizophrenia cohortJ Mallet, Y Le Strat, F Schürhoff, et al.
European Archives of Psychiatry and Clinical Neuroscience|July 19, 2022
The impact of parent history of severe mental illness on schizophrenia outcomes: results from the real-world FACE-SZ cohortA Garosi, P L Sunhary de Verville, D Etchecopar-Etchart, et al.
Journal of Affective Disorders|July 16, 2020
Major depression, sleep, hostility and body mass index are associated with impaired quality of life in schizophrenia. Results from the FACE-SZ cohortG Fond, T Korchia, P L Sunhary de Verville, et al.
European Archives of Psychiatry and Clinical Neuroscience|March 29, 2017
Benzodiazepine long-term administration is associated with impaired attention/working memory in schizophrenia: results from the national multicentre FACE-SZ data setGuillaume Fond, F Berna, L Boyer, et al.
Schizophrenia Research|September 11, 2017
Risk factors for increased duration of untreated psychosis. Results from the FACE-SZ datasetG Fond, L Boyer, M Andrianarisoa, et al.
Journal of Affective Disorders|December 18, 2015
Peripheral sub-inflammation is associated with antidepressant consumption in schizophrenia. Results from the multi-center FACE-SZ data setG Fond, O Godin, L Brunel, et al.
Pageof 5